Is ATAI Life Stock a Good Investment?
ATAI Life Investment Advice | ATAI |
- Examine ATAI Life's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research ATAI Life's leadership team and their track record. Good management can help ATAI Life navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact ATAI Life's business and its evolving consumer preferences.
- Compare ATAI Life's performance and market position to its competitors. Analyze how ATAI Life is positioned in terms of product offerings, innovation, and market share.
- Check if ATAI Life pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about ATAI Life's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in ATAI Life Sciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if ATAI Life Sciences is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Modest | Details | |
Volatility | Extremely Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine ATAI Life Stock
Researching ATAI Life's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 29.0% of the company shares are held by institutions such as insurance companies. The book value of ATAI Life was presently reported as 0.69. The company recorded a loss per share of 0.93. ATAI Life Sciences last dividend was issued on the 27th of August 2018.
To determine if ATAI Life is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding ATAI Life's research are outlined below:
| ATAI Life Sciences is way too risky over 90 days horizon | |
| ATAI Life Sciences may become a speculative penny stock | |
| ATAI Life Sciences appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 308 K. Net Loss for the year was (150.05 M) with profit before overhead, payroll, taxes, and interest of 308 K. | |
| ATAI Life Sciences currently holds about 304.06 M in cash with (82.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from finance.yahoo.com: Atai Life Sciences Full Year 2024 Earnings Misses Expectations |
ATAI Life Quarterly Liabilities And Stockholders Equity |
|
ATAI Life uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in ATAI Life Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ATAI Life's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact ATAI Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises ATAI Life's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-03-28 | 2023-12-31 | -0.16 | -0.12 | 0.04 | 25 | ||
2023-03-24 | 2022-12-31 | -0.23 | -0.28 | -0.05 | 21 | ||
2023-11-14 | 2023-09-30 | -0.2 | -0.28 | -0.08 | 40 | ||
2025-03-26 | 2024-12-31 | -0.15 | -0.24 | -0.09 | 60 | ||
2021-08-16 | 2021-06-30 | -0.18 | -0.37 | -0.19 | 105 | ||
2024-08-06 | 2024-06-30 | -0.16 | -0.36 | -0.2 | 125 | ||
2022-03-30 | 2021-12-31 | -0.23 | -0.62 | -0.39 | 169 | ||
2021-05-27 | 2021-03-31 | 0.01 | -0.57 | -0.58 | 5800 |
Know ATAI Life's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as ATAI Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ATAI Life Sciences backward and forwards among themselves. ATAI Life's institutional investor refers to the entity that pools money to purchase ATAI Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Blackrock Inc | 2024-12-31 | 314.5 K | Advisorshares Investments, Llc | 2024-12-31 | 311.5 K | Susquehanna International Group, Llp | 2024-12-31 | 307.3 K | Bank Of America Corp | 2024-12-31 | 287.5 K | Catalio Capital Management, Lp | 2024-12-31 | 196.9 K | Goldman Sachs Group Inc | 2024-12-31 | 171.6 K | Hyperion Capital Advisors Lp | 2024-12-31 | 168.4 K | Barclays Plc | 2024-12-31 | 165 K | Xtx Topco Ltd | 2024-12-31 | 140.5 K | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 3.3 M | Ubs Group Ag | 2024-12-31 | 1.9 M |
ATAI Life's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 287.54 M.Market Cap |
|
ATAI Life's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.96) | (1.01) | |
| Return On Capital Employed | (0.76) | (0.80) | |
| Return On Assets | (0.94) | (0.98) | |
| Return On Equity | (1.28) | (1.22) |
Determining ATAI Life's profitability involves analyzing its financial statements and using various financial metrics to determine if ATAI Life is a good buy. For example, gross profit margin measures ATAI Life's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of ATAI Life's profitability and make more informed investment decisions.
Evaluate ATAI Life's management efficiency
ATAI Life Sciences has return on total asset (ROA) of (0.2754) % which means that it has lost $0.2754 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8316) %, meaning that it created substantial loss on money invested by shareholders. ATAI Life's management efficiency ratios could be used to measure how well ATAI Life manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1.01. The current Return On Capital Employed is estimated to decrease to -0.8. As of now, ATAI Life's Total Assets are increasing as compared to previous years. The ATAI Life's current Non Currrent Assets Other is estimated to increase to about 45.1 M, while Net Tangible Assets are projected to decrease to under 216.5 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.73 | 0.69 | |
| Tangible Book Value Per Share | 0.71 | 0.67 | |
| Enterprise Value Over EBITDA | (1.40) | (1.47) | |
| Price Book Value Ratio | 1.83 | 1.92 | |
| Enterprise Value Multiple | (1.40) | (1.47) | |
| Price Fair Value | 1.83 | 1.92 | |
| Enterprise Value | 203.1 M | 200.3 M |
Evaluating the management effectiveness of ATAI Life allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The ATAI Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Beta 1.186 |
Basic technical analysis of ATAI Stock
As of the 23rd of March, ATAI Life owns the coefficient of variation of 2105.71, and Market Risk Adjusted Performance of 0.2189. ATAI Life Sciences technical analysis gives you the methodology to make use of past data patterns to determine a pattern that approximates the direction of the firm's future prices.ATAI Life's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ATAI Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on ATAI Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ATAI Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
ATAI Life's Outstanding Corporate Bonds
ATAI Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ATAI Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ATAI bonds can be classified according to their maturity, which is the date when ATAI Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Understand ATAI Life's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing ATAI Life's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0509 | |||
| Market Risk Adjusted Performance | 0.2189 | |||
| Mean Deviation | 5.07 | |||
| Semi Deviation | 6.39 | |||
| Downside Deviation | 6.64 | |||
| Coefficient Of Variation | 2105.71 | |||
| Standard Deviation | 7.07 | |||
| Variance | 50.01 | |||
| Information Ratio | 0.0556 | |||
| Jensen Alpha | 0.4309 | |||
| Total Risk Alpha | 0.8629 | |||
| Sortino Ratio | 0.0592 | |||
| Treynor Ratio | 0.2089 | |||
| Maximum Drawdown | 35.09 | |||
| Value At Risk | (10.61) | |||
| Potential Upside | 14.35 | |||
| Downside Variance | 44.14 | |||
| Semi Variance | 40.85 | |||
| Expected Short fall | (5.11) | |||
| Skewness | 0.791 | |||
| Kurtosis | 1.58 |
| Risk Adjusted Performance | 0.0509 | |||
| Market Risk Adjusted Performance | 0.2189 | |||
| Mean Deviation | 5.07 | |||
| Semi Deviation | 6.39 | |||
| Downside Deviation | 6.64 | |||
| Coefficient Of Variation | 2105.71 | |||
| Standard Deviation | 7.07 | |||
| Variance | 50.01 | |||
| Information Ratio | 0.0556 | |||
| Jensen Alpha | 0.4309 | |||
| Total Risk Alpha | 0.8629 | |||
| Sortino Ratio | 0.0592 | |||
| Treynor Ratio | 0.2089 | |||
| Maximum Drawdown | 35.09 | |||
| Value At Risk | (10.61) | |||
| Potential Upside | 14.35 | |||
| Downside Variance | 44.14 | |||
| Semi Variance | 40.85 | |||
| Expected Short fall | (5.11) | |||
| Skewness | 0.791 | |||
| Kurtosis | 1.58 |
Consider ATAI Life's intraday indicators
ATAI Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ATAI Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
ATAI Life time-series forecasting models is one of many ATAI Life's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ATAI Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
ATAI Stock media impact
Far too much social signal, news, headlines, and media speculation about ATAI Life that are available to investors today. That information is available publicly through ATAI media outlets and privately through word of mouth or via ATAI internal channels. However, regardless of the origin, that massive amount of ATAI data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ATAI Life news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ATAI Life relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ATAI Life's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ATAI Life alpha.
ATAI Life Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards ATAI Life can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
ATAI Life Sciences Historical Investor Sentiment
Investor biases related to ATAI Life's public news can be used to forecast risks associated with an investment in ATAI. The trend in average sentiment can be used to explain how an investor holding ATAI can time the market purely based on public headlines and social activities around ATAI Life Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ATAI Life's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ATAI Life and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average ATAI Life news discussions. The higher the estimate score, the more favorable the investor's outlook on ATAI Life.
ATAI Life Corporate Management
| Ryan Barrett | General VP | Profile | |
| Ryan JD | General Secretary | Profile | |
| Rolando MD | Chief Officer | Profile | |
| Stephen Bardin | Advisor | Profile | |
| Michael Raven | Senior Operations | Profile | |
| Madison Crawford | Sr Accounting | Profile | |
| Glenn Short | Senior Development | Profile |
Already Invested in ATAI Life Sciences?
The danger of trading ATAI Life Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of ATAI Life is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than ATAI Life. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile ATAI Life Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether ATAI Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ATAI Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atai Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atai Life Sciences Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ATAI Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATAI Life. If investors know ATAI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATAI Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.97) | Earnings Share (0.93) | Revenue Per Share | Quarterly Revenue Growth (0.54) | Return On Assets |
The market value of ATAI Life Sciences is measured differently than its book value, which is the value of ATAI that is recorded on the company's balance sheet. Investors also form their own opinion of ATAI Life's value that differs from its market value or its book value, called intrinsic value, which is ATAI Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATAI Life's market value can be influenced by many factors that don't directly affect ATAI Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between ATAI Life's value and its price, as these two are different measures arrived at by various means. Investors typically determine if ATAI Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATAI Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.